Search Results - "Shaefer, Charles F."

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes by Chamberlain, James J, Rhinehart, Andrew S, Shaefer, Jr, Charles F, Neuman, Annie

“…The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers,…”
Get full text

User's guide to mechanism of action and clinical use of GLP-1 receptor agonists by Shaefer, Charles F, Kushner, Pamela, Aguilar, Richard

“…Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are injectable glucose-lowering medications approved for the treatment of adult patients with type…”
Get full text

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies by Shaefer, Jr, Charles F

“…In Brief In the past decade, various incretin-based therapies have emerged in clinical practice. These drugs, including dipeptidyl peptidase-4 inhibitors and…”
Get full text

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus by Anderson, John E., Wright, Eugene E., Shaefer, Charles F.

“…Empagliflozin is an oral treatment for type 2 diabetes mellitus (T2DM), one of the leading causes of death in the US and around the world. Recently, the…”
Get full text

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects by Shaefer, Charles F., Jr

“…[...]GLP-1 receptor agonist therapy is one of the recommended treatment strategies offering a low incidence of hypoglycemia, an important aspect of diabetes…”
Get full text

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes by Chamberlain, James J., Rhinehart, Andrew S., Shaefer, Charles F., Neuman, Annie

Get full text

The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin by Shaefer, Charles F., Anderson, John

“…Diabetes, mainly type 2 diabetes mellitus (T2DM), is associated with a growing clinical and economic burden in the United States, which is expected to increase…”
Get full text

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes by Shaefer, Charles F., Reid, Timothy S., Dailey, George, Mabrey, Melanie E., Vlajnic, Aleksandra, Stuhr, Andreas, Stewart, John, Zhou, Rong

“…Background: An increase in body weight is a commonly perceived effect of insulin therapy for type 2 diabetes mellitus, and this may serve as a barrier to…”
Get full text

Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions by Rich, Paul A, Shaefer, Charles F, Parkin, Christopher G, Edelman, Steven V

“…The 5-year conversion rate from prediabetes to type 2 diabetes ranges from 10%7 to 23%8 depending on the diagnostic criteria used. Because considerable…”
Get full text

The Good Old Days Were Not So Good for Inpatient Care by Shaefer, Charles F

Get full text

Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point? by Shaefer, Jr, Charles F.

Get full text

In search of the holy grail? The quest to reduce macrovascular disease in type 2 diabetes mellitus by Shaefer, Charles F.

Get full text

The pen is mightier than the sword by Shaefer, Charles F.

“…Rubin and Peyrot 20 summarized the situation well, saying “physicians, patients, and payors should recognize that making it easier for patients to take better…”
Get full text

The perfect storm? by Shaefer, Charles F.

Get full text

Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes by Shaefer, Charles F.

“…Summary Even the finest coffee bean in the world, if used in the wrong proportion to water, yields a substandard cup of java. The coffee must be used in the…”
Get full text

Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points by Shaefer, Charles F.

“…Background: Type 2 diabetes mellitus (DM) is appearing in adults at an epidemic rate. Primary care clinicians will, out of necessity, provide diabetes care for…”
Get full text

Sunshine on a rainy day: Good news for diabetes by Shaefer, Charles F.

Get full text

Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview by Shaefer, Charles F.

“…Diabetes is a growing problem in the primary care office. Microvascular and macrovascular complications are a frequent result of this disease. Fewer…”
Get full text

Afloat in a rising sea of type 2 diabetes: Looking for lighthouses in the 4-T trial by Shaefer, Charles F.

Get full text

Is diabetes mellitus ready for the “Do It Yourself” approach? by Shaefer, Charles F.

Get full text